Back to search
FDAFDA · Food and drugs·Recall number D-1258-2020

Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-02

Published April 8, 2020 · Recall initiated: March 25, 2020

Summary

FDA records drug Class III recall D-1258-2020, published April 8, 2020 and initiated March 25, 2020. Recalling firm: Akorn Inc; Status: Terminated; Reported quantity: 15,170 ampules; Lot: Lot 081887A, EXP 08/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn Inc
Distributor
Distributed Nationwide in the USA
Lot
Lot 081887A, EXP 08/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl Citrate Injection, USP, 100 mcg/2 mL (50 mcg/mL), 10 Ampules per carton, (2 mL each), Rx only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-030-02 recalled?

Yes. FDA published recall D-1258-2020 on April 8, 2020. Reported hazard: Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter